Pharmacy Daily for Wed 10 Sep 2014 - OTC nasal statements ticked, Chinese medical register check,...

8/11/2019 Pharmacy Daily for Wed 10 Sep 2014 - OTC nasal statements ticked, Chinese medical register check, E-cigs = re

1/4

Wednesday 10 Sep 2014 PHA RMAC YDAI LY.COM.AU

Pharmacy Daily Wednesday 10th September 2014 t 1300 799 220 w www.pharmacydaily.com.au page 1

Grow your OTC proftAPOTEX is reminding pharmacists w h -fu

y OTC p w hAporyl.

S f h b u ck w h f p f roduct training on p age four.

Always read the label. Use only as directed.

THE EASY WAY TO HELP YOU STAY WELL THIS COLD AND FLU SEASON

Ethical Nutrients Immune Defence may reduce theseverity and duration of a cold and support a

healthy immune system.

healthnotes .com.au

PROFESSIONAL PHARMACY SERVICESNOW AVAILABLE

Subscribe Now

GuildLink limited bundle deal offerexpires 30th September 2014!

your business as part ofone software solution

Link up unique opportunities in front of shop + professional services

APHS rebrands as Epic

APHS Pharmacy has rebranded asEp c Ph cy, w h cu -u f w .

The company signalled its newk w k (PD 03 Sep), with

p C h R w her websitethat thep f

f acronyms in the industry meant itw f ch .

Th (pictured ) had beencrowdsourced, Reid said.

Th ub b b f,

Ep c p k p .R Ep c h f u

company values: Energy, Purpose,Innovate and Connect.

Th w u u coming months, the company said.

OTC nasal statements tickedTHE Th p u c GA (TGA) h c

y f hcounter topical nasal decongestantsp p f w c u .

Th TGA w u p p D u f h h y

u by cor pharmacists to be included on

h b f p pcontaining methoxamine,naphazoline, oxymetazoline,phenylephrine, tetrahydrozoline,tramazoline, tymazoline andxylometazoline.

Some submissions to thec u u chthe three day period but theTGA w pp p fseveral reasons, including thatit was endorsed by the AdvisoryC f N -p c pMedicines.

Th TGA p p hstatement Frequent or prolongedu y c u c

cu w f c u b f p p , w h hj y f ub upp

this.T p p ,

CLICK HERE.MEANWHILE h TGA h

supported an amended advisory

f OTC c u h cf u .

The amended statement removes w f h p p

, If c u h p worsens, consult your doctor orpharmacist.

Th TGA h phrase was unnecessary as itcould be considered similar to apersistent cough.

Acc y, h uc the OTC medicine monographf Ph c w

c h , h TGA .CLICK HERE p p

statements.

Epic video conferenceTHE newly launched Epic

Ph cy h u p -ph c c f c

p by Oc b .Partner Cathie Reid said the

company was rolling out a seriesf ch y , b h

h w w , pp h hc p f

u c c .O uch, u pp f P ,

had already been launched andothers would be coming soon, Reidsaid.

Psychotropics anddementia

RESEARCHpublished in Drugsnd Aging has said psychotropicsh u b b c u f h

c k f uc u c

wh p c b f p w h.

I k p c 19 h cute geriatric ward specialising in

, 93 p .CLICK HERE to read more.

Soliris PBS meetingTHE D p f H h y y

eleased an outcome statement 24 Ju k h

cu h PBS f

( cu zu b) f yp cy c u c y .

C uc cu w kowards a prescribing criteria underManaged Entry Scheme.
http://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defencehttp://www.pharmacydaily.com.au/click?http://www.healthnotes.com.au/http://www.pharmacydaily.com.au/click?http://www.healthnotes.com.au/http://www.pharmacydaily.com.au/click?http://www.healthnotes.com.au/http://www.pharmacydaily.com.au/click?http://www.healthnotes.com.au/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://pharmacydaily.com.au/click?http://tga.gov.au/newsroom/consult-otc-nasal-decongestant-140328.htm#.VA58qfmSxxAhttp://pharmacydaily.com.au/click?http://tga.gov.au/newsroom/consult-otc-cough-medicines-140328-submissions.htm#.VA5_T_mSxxAhttp://pharmacydaily.com.au/click?http://link.springer.com/article/10.1007/s40266-014-0206-0http://pharmacydaily.com.au/click?http://link.springer.com/article/10.1007/s40266-014-0206-0http://pharmacydaily.com.au/click?http://tga.gov.au/newsroom/consult-otc-cough-medicines-140328-submissions.htm#.VA5_T_mSxxAhttp://pharmacydaily.com.au/click?http://tga.gov.au/newsroom/consult-otc-nasal-decongestant-140328.htm#.VA58qfmSxxAhttp://www.pharmacydaily.com.au/click?http://www.guildlink.com.au/patient-care/guildsmartsubscription/http://www.pharmacydaily.com.au/click?http://www.webstercare.com.au/shop/category/medsprohttp://www.pharmacydaily.com.au/click?http://www.healthnotes.com.au/http://www.pharmacydaily.com.au/click?http://www.ethicalnutrients.com.au/content/products/immune-defence


2/4


Pharmacy Daily Wednesday 10th September 2014 t 1300 799 220 w www.pharmacydaily.com.au page 2

September 2014

NEW PRODUCTS

Feiba-NF (factor VIII inhibitorbypassing fraction) containsfactor II, IX, X (nonactivated),factor VII (activated) and 1-6 U/mLof factor VIII coagulation antigen.

Feiba-NF is prepared from pooledhuman plasma. Feiba-NF isindicated for routine prophylaxis,control of spontaneous bleedingepisodes and use in surgery inhaemophilia A or B patients withinhibitors. The use of Feiba-NFis contraindicated in patientswho are known to have a normalcoagulation mechanism. It shouldnot be given to patients withsigni cant signs of disseminatedintravascular coagulation (DIC)or brinolysis. In patients withtentative or de nite diagnosis ofcoronary heart disease as well as inpatients with acute thrombosis and/or embolism the use of Feiba-NF

is only indicated in life threateningbleeding events. Feiba-NF iscontraindicated in cardiac surgeryinvolving cardiopulmonarybypass and procedures involvingextracorporeal membraneoxygenation (ECMO) due to the highrisk of thrombotic adverse events.

Feiba-NF is available as a powderfor injection with solvent in singledose glass vials in 500, 1000 and2500 units.

Mirvaso (brimonidine) containsa selective 2-adrenergic receptor

agonist that is 1000-fold moreselective for the 2-adrenergicreceptor than the 1-adrenergicreceptor. Topical facial applicationof a highly selective 2-adrenergicreceptor agonist is intended toreduce erythema through directcutaneous vasoconstriction.Mirvaso is indicated for thetreatment of facial erythemaof rosacea in adults. It iscontraindicated in children under18 years of age; therapy withconcomitant monoamine oxidaseinhibitor (MAOI) and with tricyclic ortetracyclic antidepressants, whichaffect noradrenergic transmission.Mirvaso is available as a gel

containing brimonidine tartrate5 mg/g ( brimonidine 3.3 mg/g) ina 30 g tube in packs of 1s.

Nimenrix (Neisseria m eningitidis polysaccharide conjugatevaccine) is indicated for activeimmunisation of individuals from theage of 12 months through 55 years

against invasive meningococcaldiseases caused by Neisseriameningitidis serogroups A, C, W-135and Y. Nimenrix is available as apowder for reconstitution + 0.5 mLsolvent in single glass vials.

Rixubis (nonacog gamma (rch)) contains recombinant human factorIX synthesised by a geneticallyengineered Chinese hamsterovary (CHO) cell line. Rixubis isindicated for the routine prophylaxisof bleeding episodes in adultswith haemophilia B; treatment andprevention of bleeding episodesin adults with haemophilia B(congenital factor IX de ciency)and peri-operative management inadults with haemophilia B. Rixubisis contraindicated in those withhypersensitivity to hamster protein.Rixubis is available as a powder forinfusion (250 IU, 500 IU, 1000 IU,2000 IU, 3000 IU) in a single useglass vial, in packs of 1s.

Stribild (tenofovir disoproxilfumarate/ emtricitabine/elvitegravir/ cobicistat) containscombination NRTIs + integrasestrand transfer inhibitor (INSTI)+ pharmacokinetic enhancerrespectively. Stribild is indicatedas a single tablet regimen for

HIV infection in treatment naiveadults. It is contraindicatedwith concomitant alfuzosin,rifampicin, ergot derivatives (egdihydroergotamine, ergonovine,ergotamine, methylergonovine),cisapride, St Johns wort,

lovastatin, simvastatin, pimozide,sildena l for PAH, oral midazolam,triazolam, other products containingsame active components(tenofovir disoproxil fumarate,emtricitabine), ritonavir, lamivudine,adefovir dipivoxil. Stribild is alsocontraindicated in children andadolescents aged less than 18yrs. Stribild is available as acombination tablet containingtenofovir disoproxil fumarate300 mg, emtricitabine 200 mg,elvitegravir 150 mg, cobicistat150 mg in packs of 30s.

SAFETY RELATED CHANGES

Adr iamy cin (doxorubicinhydrochloride) is nowcontraindicated for IV use inthe following conditions: severemyocardial insuf ciency, recent MI,severe liver impairment, presenceof generalised infection and inpersistent myelosuppression.

Adriamycin for intravesical useis now contraindicated withhaematuria.

Daonil (glibenclamide) is nowcontraindicated in the treatment ofdiabetic ketoacidosis.

Telzir (fosamprenavir calcium) is now contraindicated withquetiapine.

NEW INDICATIONS

Simponi (golimumab (rmc)) isnow indicated in the treatmentof moderately to severely activeulcerative colitis in adult patientswho have had an inadequateresponse to conventional therapy.Patients should show a clinicalresponse within 6 weeks oftreatment to continue treatmentbeyond that time.

This list is a summary of only someof the changes that have occurredover the last month. Beforeprescribing, always refer to the fullproduct information.

End-to-endprofessionalservices solutions

Contact: Le anne Bauckham on02 9248 2614 or [email protected]

www.instigo.com.au

WIN AN

INNOXA PACKThis week PD& Innoxa aregiving fivereaders thechance to winan Innoxaprize pack.Innoxa hasbeen caring forskin with Dermatologically tested,cruelty free skincare ranges.The Restore Lift & Firm Primerprovides hydration. The PoreVanishing Crme is the perfectpick me up that minimises pores.For a mascara that lengthens andcurls whilst conditioning, LushLashes Mascara is one to try. Forthose multi taskers, the 2 in 1Liner and Eyeshadows are greatfor touch ups on the go.Visit: www.innoxa.com.auTo win, be first to send thecorrect answer to:[email protected]

Does Innoxa teston animals?

Congratulations to yesterdayswinner, Sue Britton fromWaverley Pharmacy.

E-cig harm reductionAN EDITORIALpublished in the

Lancet k b u h ucu k c wh

c -c .The editorial concluded that,

unless reliable evidence showed-c w c

c , h w ju c f h .

H w h p b y f h

uc h u b h ydismissed and robust evidence was

- CLICK HERE f .

Chinese medicalregister check

THE Ch M c B fAu h p h uh ck h Ch c

c , y p c .

This included Chinese herbalc p c h b

dispensers, the Board said.C u w b ch ck

his by going to the Boardsw b , N B ch fCh c P f Ch

Xue said.Th w u w p f h

p f Ch c p c

h , Xu .Th p w u Jux y h c w c c u

k w w c yf h , Xu .

A f M ch h y , h w,219 registered Chinese medicine

c Au , w h 122

-p c h j y1,707) NSW.For more, CLICK HERE.

Education eveningsARTHRITISand Osteoporosis

NSW h f uc u b ck p , w h

k y p k h u DDavid Spencer, in Cowra.

Th f h hc p f (HCP)c f u CPD p , A hAustralia said.

Th c p fthe Rural Outreach Project, whichaims to provide local rheumatology

c c uc c u HCP .

Call 1800 011 041 to register.

E-cigs = regular cigsTHE H F u

Queensland has welcomed theS G

-c u h w u c .

This means people can not useh y k f z ,

wh ch p cu y pin Queensland which has led thew y w h k f , H F u (HF) QLD h hdirector, Rachelle Foreman.

E-c fu h f c p x h h p b ,

she said.If h -c

unregulated then they can provide y p hw y k

f ch , wh ch w u b.

A c H F u yf k p c f u 11u f 19 Qu wb h (18%)

f p pu f k .Th H F u c f

c f -c w k -f

w pp y -c w u c y.
http://www.pharmacydaily.com.au/click?http://www.instigo.com.au/http://www.pharmacydaily.com.au/click?http://www.instigo.com.au/http://www.pharmacydaily.com.au/click?http://www.instigo.com.au/http://www.pharmacydaily.com.au/click?http://www.instigo.com.au/mailto:leanne%40instigo.com.au?subject=Enquiryhttp://www.pharmacydaily.com.au/click?http://www.instigo.com.au/mailto:leanne%40instigo.com.au?subject=Enquiryhttp://www.pharmacydaily.com.au/click?http://www.instigo.com.au/mailto:comp%40pharmacydaily.com.au%0D?subject=Innoxa%20comphttp://pharmacydaily.com.au/click?http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61470-7/fulltexthttp://pharmacydaily.com.au/click?http://www.chinesemedicineboard.gov.au/News/2014-09-04-media-release.aspxhttp://pharmacydaily.com.au/click?http://www.chinesemedicineboard.gov.au/News/2014-09-04-media-release.aspxhttp://pharmacydaily.com.au/click?http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61470-7/fulltextmailto:comp%40pharmacydaily.com.au%0D?subject=Innoxa%20compmailto:leanne%40instigo.com.au?subject=Enquiryhttp://www.pharmacydaily.com.au/click?http://www.instigo.com.au/


3/4


rmacy Daily is a publica on for health professionals of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain wri en permission from the editor to reproduce any material. While every care has been taken in theprepara on of Pharmacy Daily no liability can be accepted for errors or omissions. Informa on is published in good faith to s mulate independent inves ga on of the ma ers canvassed. Responsibility for editorial is taken by Bruce Piper.

itors Bruce Piper, Alex Walls & Mal Smith email f @ph cy y.c . u advertising K F @ph cy y.c . u page 3

Health, Beautyand New Products

Welcome to our weekly feature withall the latest health, beauty and newproducts for pharmacy!

Suppliers wan ng to promote products inthis feature should [email protected]

Cost Efective Targeted Easy

For details call us today: 1300 799 220

Advertise with us

. .

Pelactiv Hydrating Skin Treatment PackCreated by Australian Skincare Therapists in conjunction with leading Biochemists,Pelactiv incorporates the purest Australian native plant extracts in combination withthe prime active ingredient, Lactic Acid. Pelactiv Skin Treatment Packs are speci callytailored to target three of the most commonly occurring skin concerns: dehydration,dryness and problematic/congested skins. Each pack contains the Pelactiv FacialRe ner Deep Cleansing Scrub 150ml, and a specialised Pelactiv Treatment Mask75ml. Now available in three varieties - as well as Hydrating , look for Purifying andNourishing.Stockists: 1800 655 745RRP: $64Website: www.pelactiv.com

New St. Tropez Self Tan Luxe Dry OilCombine a campaign fronted by supermodel and St.Tropez Global Ambassador Kate Moss, thelatest in intelligent self-tanning technology and a luxe Brazilian inspired dry oil with multipleskincare bene ts and you get St. Tropez Self Tan Luxe Dry Oil . With its deluxe, fast-drying,non-greasy and easy-to-apply dry-oil base, St.Tropez Self Tan Luxe Dry Oil leaves skin supple,nourished and perfectly conditioned for up to seven days. St.Tropez Self Tan Luxe Dry Oil uses

a 100% natural tanning agent and is also paraben, sulphate and phthalate free.Stockist: 1300 819 331RRP: $49.99Website: www.sttropeztan.com.au

Verona maintaining the natural balance of a womans V zoneA new preventative, pharmacy-only, feminine hygiene brand is set to more than doubleintimate care category pro ts for Australian pharmacy by 2017. Verona is a unique,clinically-proven range of intimate daily washes, specially formulated to care for the mostsensitive area of a womans body. Verona is designed to help women feel clean andfresh while protecting them from unwanted irritations that occur during the daily

life of a busy woman. The four-variant product range is tailored to the di erentlife stages of a woman from puberty and menstruation, to pregnancy andmenopause.Stockist: 02 9847 7999.RRP: $9.95 eachWebsite: www.verona.com.au

You can manage your childs eczema with Gaia Baby MoisturiserEczema can a ect all ages. It usually appears in early childhood (in babies between two-to-six

months of age) and disappears around six years of age says Gaia. The good news is mostchildren grow out of the condition but some may experience eczema into adulthood althoughthe exact cause of eczema is unknown. Gaia recommends that you cleanse, moisturise andprotect the skin. Apply moisturiser gently, without rubbing, within three minutes of bathing(while the skin is still slightly damp) to lock in the moisture, and apply daily. Gaias range ofwashes, moisturisers and lotions include Gaia Baby Moisturiser .Stockists: 03 9703 1707RRP: $11.50Website: www.gaiaskinnaturals.com

DISPENSARYCORNER

A MELBOURNE man has literallyhad a crash course in language,

w k f c h h c u y p k Ch .22 year old Ben McMahon was

injured in a car accident, andwh h w k , p y

by u w h A f uI f y h uMandarin.

H h k f p paper and was able to write asentence in Mandarin.

D p k ycourse at school he had neverb y p k h

u , w h h w-f uk b c , cc

to a report in the UK Mirror .App y k h b uh y c h w p k

E h, bu h b p k Ch h

Shanghai to study commerce.

ANOTHER c y f c c .Researchers in the UK have

f u h f c ch cteapot is not actually useless.

Th f h NP uc T ch y C Y k

c k up h chand created a special vessel bybu up p c yp f kch c f y .

Th u p (picturedbelow ) was able to withstandb w f w u -

p y f f h b wb f p u .

The experiment was broadcast h BBC, w h ch f ch

J h C y w k fh w .

When you pour it, whathappens is that the chocolate on

h f h h budoesnt move anywhere.

Th u y cup f w h h h f ch c .
mailto:newproducts%40pharmacydaily.com.au?subject=http://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.auhttp://www.pharmacydaily.com.au/click?http://www.pharmacydaily.com.aumailto:newproducts%40pharmacydaily.com.au?subject=


4/4

Grow your anti-fungal nail treatment

category and OTC proft with

* Turnover orders only bonus stock offer not available via PDE. ** Contact your Apotex Territory Manager for Point of Sale Materials and Product Training.1. Apotex Pty Ltd, Data on file.2. Apotex Pty Ltd, Aporyl Consumer Medicine Information, December 2012.3. A. Menarini Australia Pty Ltd, Rejuvenail Instructions for use,Rejuvenail website. http://www. rejuvenail.com.au/about-rejuvenail; Accessed May 01 2014.

ALWAYS READ THE LABEL. USE ONLY AS DIRECTED. IF SYMPTOMS PERSIST SEE YOUR HEALTHCARE PROFESSIONAL. Apotex Pty Ltd, Macquarie Park NSW 2113, ABN 52 096 916 148. Apotex Pty Ltd is the licensee of the registered trade mark APOTEX from the registered proprietor, Apotex Inc. APORYL is a trade mark of Apotex Technologies, Inc. Copyright 2014. All rights reserved. www.apotex.com.au PM-AU-0674 August 2014

amorolfne 5% w/v as the hydrochloride

Works in the same way as Loceryl1

with fewer applications than Rejuvenail2,3

ORDER NOWCall your Apotex Territory Manageror Sales SupportP: 02 8877 8343E: [email protected]

BONUS S

TOCK OFF

ER*

FREE POIN

T OF S A L

E M A T ERI

A LS & PR

ODUCT T R A

INING**
mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.mailto:[email protected]?subject=APORYL%20bonus%20free%20stock%20offer&body=Dear%20Apotex%20Sales%20Support,%20%0D%0A%0D%0AI%20would%20like%20further%20details%20on%20the%20APORYL%20bonus%20free%20stock%20offer.%0D%0A%0D%0ACan%20you%20please%20contact%20me%20or%20provide%20me%20with%20the%20details%20of%20the%20Apotex%20Territory%20Manager%20for%20my%20area.%20%0D%0A%20%0D%0AThank%20you.

Pharmacy Daily for Wed 10 Sep 2014 - OTC nasal statements ticked, Chinese medical register check,...

Documents

Transcript of Pharmacy Daily for Wed 10 Sep 2014 - OTC nasal statements ticked, Chinese medical register check,...